Evidence map›Paper›PMID 42311547›Full record

ArticleJournal of the ASEAN Federation of Endocrine Societies2026

Prevalence and Impact of Hypothyroidism on Glycaemic Control in Indian Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.

J Rawat, Aviral Rawat

Abstract read
In one paragraph

Article in Journal of the ASEAN Federation of Endocrine Societies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

J RawatDepartment of Endocrinology and Diabetology, Seghal Neo Hospital, New Delhi, India.
Aviral RawatSri Ramaswamy Memorial (SRM) Medical College, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to determine the prevalence of hypothyroidism in Indian patients with T2DM and explore its impact on glycemic control and comorbidities. Methodology: This cross-sectional study involved 218 patients with T2DM attending a tertiary care centre. Patient demographics, comorbidities, and blood samples were collected to measure glycosylated haemoglobin (HbA1c) and thyroid-stimulating hormone (TSH) levels. Patients were classified as euthyroid, hyperthyroid, or hypothyroid based on TSH levels. A sub-analysis compared demographic and biochemical parameters between euthyroid and hypothyroid groups. Results: The study included 218 patients with T2DM with a mean age of 57.6 ± 11.1 years, and a female predominance (54.1%). The prevalence of hypothyroidism was 58.7%, higher among females. No significant differences in comorbidities or HbA1c levels were observed between euthyroid and hypothyroid patients. Among patients with HbA1c ≥6.4%, women showed a higher prevalence of hypothyroidism. Conclusion: The high prevalence of hypothyroidism among patients with T2DM, particularly in females, underscores the need for routine thyroid function screening in this population. Despite the lack of significant differences in comorbidities or glycaemic control between euthyroid and hypothyroid patients seen in this study, the potential impact of thyroid dysfunction on diabetes management warrants further investigation.

Indexed as

Diabetes Mellitus, Type 2Glycemic ControlHypothyroidismAdultAgedBlood GlucoseComorbidityCross-Sectional StudiesFemaleGlycated HemoglobinHumansIndiaMaleMiddle AgedPrevalenceThyrotropinBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanThyrotropincomorbiditiesglycaemic controlhypothyroidismthyroid dysfunctiontype 2 diabetes mellitus

Identifiers

PMID42311547
PMCPMC13269360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.